| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 2002 | 2019 | ||||||||
|
5'-nucleotidase, cytosolic II | 0.537 | 0.846 | 2.1E-06 |
|
group | 0.400 | None | 0.900 | 0 | 0 | 2003 | 2019 | ||||||||
|
EPH receptor A3 | 0.497 | 0.692 | 1.2E-05 |
|
group | 0.400 | None | 0.933 | 0 | 0 | 2010 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.400 | None | 0.976 | 0 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.400 | None | 0.987 | 0 | 0 | 1994 | 2019 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.962 | 0 | 0 | 2004 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 1995 | 2019 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.600 | None | 0.968 | 0 | 0 | 1993 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 1995 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1987 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.400 | None | 0.978 | 0 | 0 | 1989 | 2020 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.982 | 0 | 0 | 2002 | 2020 | ||||||||
|
aurora kinase A | 0.475 | 0.731 | 0.87 |
|
group | 0.400 | None | 0.979 | 0 | 0 | 2004 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.400 | None | 0.966 | 0 | 0 | 1986 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.600 | None | 0.972 | 0 | 0 | 1987 | 2020 | ||||||||
|
colony stimulating factor 1 receptor | 0.448 | 0.808 | 0.13 |
|
group | 0.600 | None | 1.000 | 0 | 0 | 1992 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.600 | None | 0.946 | 0 | 0 | 1994 | 2020 | ||||||||
|
cyclin dependent kinase 6 | 0.471 | 0.731 | 0.98 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 1995 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1997 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.400 | None | 0.969 | 0 | 0 | 1985 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
group | 0.400 | None | 0.977 | 0 | 0 | 1992 | 2020 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
group | 0.400 | None | 1.000 | 0 | 0 | 2011 | 2020 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.988 | 0 | 0 | 1997 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
group | 0.400 | None | 0.979 | 0 | 0 | 2003 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.945 | 0 | 0 | 1992 | 2020 |